Methyl 6-bromoimidazo[1,2-a]pyridine-8-carboxylate, 95.0%, 2.5g

8-Bromo-N-methylquinoline-4-carboxamide, 97%, 1g

4-Amino-2,3-dimethylphenol, 95.0%, 10g

Ethyl 4-methyl-2-(methylthio)pyrimidine-5-carboxylate, 95.0%, 25g

2-Iodobenzyl Bromide>98.0%(GC)5g

2-((5-Nitropyrimidin-2-yl)oxy)ethanol, 10g

4-Propyl-2,3'',4'',5''-tetrafluoro-1,1':4',1''-terphenyl, 95.0%, 5g

N-Acetylimidazole>98.0%(GC)(T)25g

Microliter syringe GASTIGHT® series 1700 Point type 2, 50 µl, 1705 RN, 1 piece

Sodium 4-isopropylbenzenesulfonate, 95%, 100g

1-Methoxy-3-(prop-2-yn-1-yloxy)benzene, 95%, 1g

3-Fluoro-4-(methylsulfonyl)benzaldehyde, 98%, 250mg

PYRIDAZINE, 3,6-DICHLORO-4-(1-METHYLETHYL)-, 95.0%, 5g